The whistle-blower has alleged that Shanghvi, Doshi and Valia made unlawful gains of ₹8,000 crore through insider trading. The probe was settled in 2017, when Sun Pharma, Shanghvi, and nine others paid ₹18 lakh to the regulator. According to norms, Sebi can reopen a case “if the terms of settlement have been violated”.
Though this is a good stock but you never know how many hidden cockroaches are in the cupboard and thus one should avoid getting trapped in such stocks in the idea of buying a value stock else one can suffer as people who bought falling stock in form of PNB, DHFL and Yes bank suffered. Remember though these good stocks but in immediate future one hould avoid it till the time some clarity emerges from SEBI.
So, as per chart time being it is better to stay away from this stock. We have earlier also discussed falling knife stocks here and not to forget our NSE BSE Intraday Stock Tips which can help you become rich.